Drug
Fludrocortisone acetate clinical trials
Also written Florinef.
A product of Fludrocortisone; its studies count on that page too.
- studies test it
- 5
- open now
- 0
- in phase 3
- 2
- first study started
- 2005
How studies write it
Studies that test it under each name
Brand
Studies by the year they started
5 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2020 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 2
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 5
The George Institute (1) · Ain Shams University (1) · University of Calgary (1) · VA Office of Research and Development (1) · Tehran Heart Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses fludrocortisone acetate is read from its arms, and is right about nine times in ten.
Testing it · 5
- Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSSCompletedPhase 2The George InstituteNCT04494789Written as Fludrocortisone Acetate
- Mineralocorticoid Use in COVID-19 PatientsCompletedPhase 3Ain Shams UniversityNCT05453214Written as Fludrocortisone Acetate 0.1 MG
- Midodrine and Fludrocortisone for Vasovagal SyncopeStatus unknownPhase 3Tehran Heart CenterNCT04595942Written as Fludrocortisone Acetate Tablets
- Clinical Trial for the Prevention of Vasovagal SyncopeCompletedPhase 4University of CalgaryNCT00118482Written as fludrocortisone acetate
- Orthostatic Hypotension in Rehabilitation PatientsCompletedNot applicableVA Office of Research and DevelopmentNCT00117585Written as Treatment Phase 2
Given in every arm · 10 — fludrocortisone acetate is usual care beside what is tested
- Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06353386Written as Fludrocortisone acetate
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06136650Written as Fludrocortisone acetate
- Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06136624Written as Fludrocortisone acetate
- A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)RecruitingPhase 2Merck Sharp & Dohme LLCNCT06979596Written as Fludrocortisone/ Fludrocortisone acetate
- A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017)CompletedPhase 1Merck Sharp & Dohme LLCNCT07548606Written as Fludrocortisone acetate
- A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)CompletedPhase 1Merck Sharp & Dohme LLCNCT06104449Written as Fludrocortisone acetate
- A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009)CompletedPhase 1Merck Sharp & Dohme LLCNCT06860243Written as Fludrocortisone acetate
- A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)CompletedPhase 1Merck Sharp & Dohme LLCNCT06814132Written as Fludrocortisone acetate
- A Drug-Drug Interaction Study of Carbamazepine and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-012)CompletedPhase 1Merck Sharp & Dohme LLCNCT06633419Written as Fludrocortisone acetate
- A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)CompletedPhase 1Merck Sharp & Dohme LLCNCT06554639Written as Fludrocortisone acetate
Codes
What other systems call fludrocortisone acetate · ClinicalTrials.gg INT003032
- MeSH (NLM) C034635fludrocortisone acetateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) V47IF0PVH4FLUDROCORTISONE ACETATEConfirmed FDA, NLM, Wikidata
- RxNorm 165516Confirmed FDA, Wikidata
- Wikidata Q27106657fludrocortisone acetateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1103Fludrocortisone AcetateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C034635 | fludrocortisone acetate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | V47IF0PVH4 | FLUDROCORTISONE ACETATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 165516 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27106657 | fludrocortisone acetate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1103 | Fludrocortisone Acetate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.